Antithyroid Medications: Methimazole and PTU

What antithyroid medicines do

The thyroid gland uses iodine to build the hormones T4 (thyroxine) and T3 (triiodothyronine). When the gland works too hard, levels of these hormones rise and the body’s metabolism speeds up. Antithyroid medicines belong to a group called thionamides. They block an enzyme called thyroid peroxidase that is needed to attach iodine to the building blocks of thyroid hormone. As a result, the gland produces less new hormone.

Existing hormone already stored inside the thyroid or circulating in the blood is not destroyed. That is why it usually takes several weeks before blood tests show clear improvement and symptoms such as rapid heartbeat, heat intolerance, or weight loss begin to settle. According to MedlinePlus, methimazole is used to treat hyperthyroidism and is also given before thyroid surgery or radioactive iodine treatment to lower hormone levels safely.

Both methimazole and propylthiouracil act inside the thyroid. PTU has an extra effect: it reduces the conversion of T4 into the more active T3 in other tissues. This extra action can be useful in certain urgent situations, but it does not change the overall need for careful medical supervision.

When methimazole or PTU may be chosen

These medicines are most often prescribed for Graves’ disease, an autoimmune condition in which the immune system stimulates the thyroid to make too much hormone. They can also be used for toxic nodular goitre or to prepare a person for definitive treatment with radioactive iodine or surgery. The goal is to bring thyroid hormone levels back into a healthy range so that symptoms ease and the risk of complications falls.

In the United Kingdom, the closely related medicine carbimazole is the usual first choice because it is converted in the body to methimazole. In the United States, methimazole itself is the standard agent for most adults who are not pregnant. PTU is reserved for specific circumstances: early pregnancy, intolerance of methimazole, or situations where other treatments are not suitable. The NHS explains that thionamide medicines stop the thyroid producing excess hormones and are commonly used for 12 to 18 months, after which some people remain well while others need further treatment.

Choice of medicine and length of treatment depend on the cause of the overactivity, the person’s age, plans for pregnancy, presence of eye problems, and personal preference. An endocrinologist or thyroid specialist weighs these factors and discusses the full range of options, which may include radioactive iodine or surgery.

How the two medicines differ

Although both medicines block thyroid hormone production, practical differences guide everyday use. Methimazole stays in the body longer, so once thyroid levels are stable it can often be taken once a day. PTU has a shorter action and is usually taken two or three times daily. This difference can affect how easy the medicine is to remember and how steadily hormone levels stay controlled.

PTU carries a higher risk of serious liver injury than methimazole. Because of this, many guidelines reserve PTU for people who cannot take methimazole or for the first trimester of pregnancy. Methimazole, on the other hand, has been linked to a small increase in certain birth defects when taken in early pregnancy, which is why PTU is often preferred at that stage. After the first trimester the balance of risks may change, and some clinicians switch back to methimazole.

Cross-sensitivity can occur: a person who develops a rash or other reaction to one medicine may also react to the other. In that situation the doctor may recommend stopping antithyroid drugs altogether and moving to radioactive iodine or surgery. Detailed information about each medicine is available in the dedicated pages on methimazole and propylthiouracil.

Monitoring during treatment

Blood tests are an essential part of safe treatment. Before starting either medicine, doctors usually check a full blood count and liver function tests. Once treatment begins, free T4 and total T3 levels are measured after a few weeks to see how the thyroid is responding. TSH may stay low for several months even after free T4 returns to the expected range, so it is not the best early guide.

As hormone levels settle, the dose is adjusted so that the person remains well without developing underactivity of the thyroid. Once a stable dose is found, testing intervals can lengthen. The Mayo Clinic emphasises that regular visits and blood tests are needed to make sure the medicine is working properly and to watch for unwanted effects.

Patients are also taught the warning signs that require an urgent full blood count: fever, sore throat, mouth ulcers, or unusual bruising. These symptoms can signal a rare drop in white blood cells. Any new jaundice, dark urine, pale stools, or upper-right abdominal discomfort prompts immediate checks of liver enzymes. Trends over time matter more than any single result, and interpretation always takes place in the context of symptoms and overall health.

Possible side effects and safety steps

Most people tolerate these medicines well, yet side effects can appear, usually in the first weeks or months. Common ones include skin rash, itching, mild joint aches, nausea, or a temporary change in taste. These often settle or can be managed without stopping the medicine. More serious reactions are uncommon but important to recognise.

A rare but serious problem is agranulocytosis, a sudden fall in the white cells that fight infection. It can occur at any time but is more often reported early in treatment. Patients are told to stop the medicine at once and seek same-day medical advice if fever, sore throat, or mouth ulcers develop. Liver injury is another rare concern, particularly with PTU. Yellowing of the skin or eyes, unexplained tiredness, loss of appetite, or dark urine require prompt evaluation.

Other uncommon reactions include joint inflammation, a lupus-like syndrome, or, very rarely, inflammation of the pancreas. Because of these possibilities, written information is usually given at the start of treatment so that patients know exactly what to watch for. Further details on recognising and responding to unwanted effects appear in the page on side effects of antithyroid drugs. According to MedlinePlus, PTU may cause severe liver damage and should only be used when other options are not suitable.

Use in pregnancy and special situations

Managing hyperthyroidism during pregnancy requires particular care because both uncontrolled hormone excess and the medicines themselves can affect the developing baby. PTU is generally preferred in the first trimester because methimazole has been associated with a higher chance of certain birth defects. After the first trimester, some specialists change to methimazole because of the greater liver risk with prolonged PTU use. Doses are kept as low as possible while still controlling the mother’s thyroid levels.

Both medicines pass into breast milk in small amounts. Many women can continue treatment while breastfeeding under close supervision, with preference often given to methimazole at the lowest effective dose. Decisions are always individual and involve discussion with an endocrinologist and obstetric team.

In children, methimazole is usually chosen over PTU because of the higher liver risk reported with PTU in younger patients. Before any major surgery or radioactive iodine treatment, antithyroid medicines are often used for a short period to bring hormone levels into a safer range. People with existing liver disease or very low white-cell counts may need alternative approaches from the start.

What everyday treatment looks like

Once the medicine is prescribed, the tablets are taken regularly, preferably at the same times each day. Missing doses can allow hormone levels to rise again, so routines that fit daily life help. Some people notice early improvement in heart rate or sleep within a few weeks; others need longer. Blood tests guide any dose changes.

Treatment for Graves’ disease is commonly continued for 12 to 18 months. After that period the medicine may be stopped and thyroid function watched closely for relapse. Roughly half of people remain well after a single course, while others experience return of overactivity and need further treatment. Long-term low-dose therapy is sometimes used when radioactive iodine or surgery is not chosen.

Beta-blockers may be added temporarily to ease symptoms such as tremor or rapid heartbeat while the antithyroid medicine takes effect. These are not a substitute for controlling the thyroid itself. Lifestyle measures—adequate rest, avoiding excess iodine supplements, and not smoking—support overall well-being but do not replace prescribed treatment. The page on side effects of antithyroid drugs also covers practical points that help patients stay safe while taking these medicines.

Talking with your doctor

Anyone starting or continuing methimazole or PTU should know when to make contact. New fever, sore throat, mouth sores, unusual bruising, yellowing of the skin, dark urine, or severe abdominal pain need same-day advice and usually an urgent blood test. Persistent or worsening symptoms of hyperthyroidism, such as marked weight loss, irregular heartbeat, or extreme fatigue, also warrant review.

Before any planned pregnancy, discussion with the thyroid team allows a treatment plan that balances the needs of mother and baby. Likewise, any new medicines, herbal products, or planned surgery should be mentioned because interactions or changes in clotting can occur. Regular follow-up appointments give the opportunity to review blood results, adjust treatment, and discuss whether a definitive option such as radioactive iodine might be appropriate.

According to Cleveland Clinic, PTU works by decreasing the amount of thyroid hormone the body makes, and patients are advised to keep taking it as directed unless the care team says otherwise. Open communication helps ensure that treatment remains both effective and as safe as possible.